AKT1 and hepatocellular carcinoma: Targetscan software revealed that Bmi-1 was a target of miR-132, which can also inactivate the protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway, suppressing proliferation, migration, and invasion in hepatocellular cancer [31].